John Nosenzo serves as Executive at Bioventus Inc., where they oversee executive responsibilities. Since joining the company, John Nosenzo has executed 12 insider transactions totaling $747.7K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jun 1, 2023 involved receiving (via award) 3,135 shares valued at $0.
John Nosenzo currently holds 6,270 shares of Bioventus Inc. (BVS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John Nosenzo has been a net seller of BVS stock. They have purchased $6.5K and sold $741.2K worth of shares.
John Nosenzo's most recent insider trade was on Jun 1, 2023, when they sold 3,135 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $7.00 |
| Planned |
| Jul 1, 2022 | BVS | $639 | Sale | 95 | $6.73 | Planned |
| Jun 1, 2022 | TELA | $0 | Award | 3,135 | $N/A | Discretionary |
| Apr 4, 2022 | BVS | $733.5K | Sale | 65,963 | $11.12 | Discretionary |
| Apr 1, 2022 | BVS | $563 | Sale | 40 | $14.07 | Planned |
| Apr 1, 2022 | BVS | $0 | Option Exercise | 106,485 | $N/A | Discretionary |
| Feb 14, 2022 | BVS | $6.4K | Sale | 534 | $11.99 | Discretionary |
| Feb 11, 2022 | BVS | $0 | Option Exercise | 1,470 | $N/A | Discretionary |
| Feb 10, 2022 | BVS | $311.8K | Payment | 24,205 | $12.88 | Discretionary |
| Feb 10, 2022 | BVS | $0 | Option Exercise | 66,139 | $N/A | Discretionary |
| Feb 11, 2021 | BVS | $6.5K | Purchase | 500 | $13.00 | Discretionary |